Rural expansion of medications for opioid use disorder (CTN-0102). DSC5 contract. 09/20/2019 - 05/15/2023. N01DA-19-2250.
Ended Awarded Last action
- Contract number
- 75N95019F00098
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,614,088
Award facts
- Opportunity
-
- 75N95019R00016 Solicitation number
- Contract value 100% obligated
- $1,614,088.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Original award | $1,614,088 |
About this award
The Emmes Company LLC was awarded a delivery order against the National Institute on Drug Abuse Data, Statistics, and Clinical Trial Support Center multiple award contract vehicle to provide support for the Rural Expansion of Medications for Opioid Use Disorder clinical trial. Valued at $1.6 million, this cost plus fixed fee contract will fund the continuation of CTN-0102 from September 2019 through May 2024. As the prime contractor, Emmes will leverage its expertise in clinical research and trial support to help the National Institute on Drug Abuse evaluate the effectiveness of medications to treat opioid use disorder in rural communities. The funding agency, the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse, aims to address the nation's opioid crisis through research into evidence-based prevention and treatment strategies.
Quick answers
Who was awarded contract 75N95019F00098?
75N95019F00098 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2019.
How much is contract 75N95019F00098 worth?
The government has obligated $1,614,088 on 75N95019F00098.
Is contract 75N95019F00098 an order under another contract?
Yes. 75N95019F00098 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95019F00098 competed?
The extent of competition for 75N95019F00098 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award